Pulse Biosciences, Inc. PLSE Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.
The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulse Biosciences, Inc.'s change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulse Biosciences, Inc.'s change in accrued liabilities?
- Pulse Biosciences, Inc. (PLSE) reported change in accrued liabilities of $1.83M in Q1 2026.
- How has Pulse Biosciences, Inc.'s change in accrued liabilities changed year-over-year?
- Pulse Biosciences, Inc.'s change in accrued liabilities increased by 160.2% year-over-year, from -$3.04M to $1.83M.
- What does change in accrued liabilities mean?
- Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.